The Committee recommends that a study estimating utility values using directly observed health-related quality of life values (such as EQ 5D scores) in patients with myelodysplastic syndromes, chronic ...
Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously ... of disease was ultimately complicated by acute disseminated encephalomyelitis and death.
The investigational immunotherapy bexmarilimab has been granted orphan drug designation from the FDA for patients with ...
Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果